Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:02 AM
Ignite Modification Date:
2025-12-26 @ 1:42 AM
NCT ID:
NCT02841033
Group ID:
EG000
Title:
Daratumumab
Description:
Daratumumab, 16mg/kg body weight in 1000 mL for the first dose, followed by 500mL for subsequent doses, once weekly for two months, then every 2 weeks for four months, then once each month for up to 24 total cycles.
Daratumumab: Daratumumab by IV infusion once weekly for two months, then every 2 weeks for four months, then once each month until progression, inability to tolerate, or 24 cycles completed.
Deaths Number Affected:
4
Deaths Number At Risk:
None
Serious Number Affected:
11
Serious Number At Risk:
22
Other Number Affected:
22
Other Number At Risk:
22
Study:
NCT02841033
Results Section:
NCT02841033
Adverse Events Module:
NCT02841033